BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 31, 2018
View Archived Issues
Sleep is depression's opposite
Read More
Novel CRISPR/Cas-mediated rat model of idiosyncratic drug-induced liver injury
Read More
First-in-human data presented for AB-023
Read More
Aspirin increases lysosomal biogenesis via PPARalpha and decreases amyloid plaque pathology in mice
Read More
Motile sperm domain-containing protein 2 promotes breast cancer cell migration and metastasis
Read More
Estrogen receptor alpha activation depends on fibronectin-beta1-integrin pathway in breast cancer
Read More
Bench and bedside: Phosphatase inhibition sheds ugly duckling status with new platform technology
Read More
Beta Cat studies BC-2059 for unresectable desmoid tumors in phase I
Read More
Primary endpoints met in phase IIb study of PRX for presbyopia
Read More
Phase III study of RHB-104 in Crohn's disease meets primary endpoint
Read More
Regenera initiates phase II study of RPh-201 in NAION
Read More
Dong-A conducts phase II study with DA-8010 in overactive bladder
Read More
First-in-human study investigates CALR exon 9 mutant peptide vaccine in CALR-mutant MPNs
Read More
Janssen studies PRMT5 inhibitor JNJ-64619178 in advanced cancers
Read More
FDA approves Azedra for pheochromocytoma or paraganglioma
Read More
Arcus cleared to begin phase I trial of anti-TIGIT antibody AB-154
Read More
Stop-gain variant in GMIP gene tied to Alzheimer's disease pathogenesis
Read More
Contactin-2 levels are altered in mild cognitive impairment
Read More
ASTRAL-1 study of guadecitabine in AML does not meet coprimary endpoints
Read More
Immutep to begin phase II study of eftilagimod alfa with pembrolizumab
Read More
Regeneus reports promising first-in-human data for autologous tumor vaccine RGSH-4-K
Read More
Phase II study of laquinimod in Huntington's disease does not meet primary endpoint
Read More
European Commission approves Aimovig to prevent migraines
Read More
HSP27 found as a potential therapeutic target for treating VCID
Read More
